Stockscreener 앱 받기
201.18
1.15%
-0.69
전일 마감가:
$201.87
열려 있는:
$203.03
하루 거래량:
46,714
Relative Volume:
0.05
시가총액:
$7.33B
수익:
$2.40B
순이익/손실:
$587.79M
주가수익비율:
12.94
EPS:
15.5461
순현금흐름:
$682.87M
1주 성능:
-10.90%
1개월 성능:
-10.73%
6개월 성능:
-27.15%
1년 성능:
-56.61%
1일 변동 폭
$199.24
$205.45
1주일 범위
$198.00
$226.38
52주 변동 폭
$185.00
$474.79
Factset Research Systems Inc Stock (FDS) Company Profile
명칭
Factset Research Systems Inc
전화
(203) 810-1000
주소
45 GLOVER AVENUE, NORWALK, CT
Compare FDS vs SPGI, CME, ICE, MCO, COIN
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FDS
Factset Research Systems Inc
|
201.25 | 7.35B | 2.40B | 587.79M | 682.87M | 15.55 |
SPGI
S P Global Inc
|
409.13 | 120.34B | 15.73B | 5.15B | 5.56B | 15.81 |
CME
Cme Group Inc
|
296.19 | 107.67B | 6.76B | 4.26B | 4.33B | 11.72 |
ICE
Intercontinental Exchange Inc
|
155.15 | 87.54B | 12.93B | 3.99B | 4.24B | 6.8684 |
MCO
Moodys Corp
|
441.25 | 76.56B | 7.87B | 2.50B | 2.75B | 13.95 |
COIN
Coinbase Global Inc
|
197.10 | 53.17B | 6.62B | 800.60M | 1.74B | 2.6593 |
Factset Research Systems Inc Stock (FDS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-17 | 재개 | BofA Securities | Underperform |
| 2025-12-17 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2025-09-22 | 업그레이드 | UBS | Neutral → Buy |
| 2025-09-12 | 업그레이드 | Rothschild & Co Redburn | Sell → Neutral |
| 2025-06-26 | 업그레이드 | Raymond James | Underperform → Mkt Perform |
| 2025-03-21 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2024-10-09 | 다운그레이드 | Redburn Atlantic | Neutral → Sell |
| 2024-10-02 | 개시 | Evercore ISI | In-line |
| 2024-08-13 | 개시 | Wells Fargo | Equal Weight |
| 2024-05-30 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2024-04-11 | 개시 | Wolfe Research | Underperform |
| 2024-03-22 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2023-12-08 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2023-08-25 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-06-15 | 재개 | BofA Securities | Neutral |
| 2023-05-15 | 개시 | BMO Capital Markets | Market Perform |
| 2023-05-09 | 개시 | Wells Fargo | Equal Weight |
| 2023-03-28 | 업그레이드 | Redburn | Sell → Neutral |
| 2023-01-12 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2022-08-26 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2022-05-17 | 개시 | Redburn | Sell |
| 2022-03-30 | 개시 | Deutsche Bank | Hold |
| 2021-12-14 | 업그레이드 | Northcoast | Sell → Neutral |
| 2021-09-30 | 업그레이드 | UBS | Sell → Neutral |
| 2021-08-25 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2021-07-08 | 개시 | RBC Capital Mkts | Outperform |
| 2020-06-11 | 다운그레이드 | Northcoast | Neutral → Sell |
| 2020-06-01 | 재개 | Oppenheimer | Perform |
| 2019-11-22 | 개시 | Jefferies | Hold |
| 2019-09-27 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2019-07-16 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2019-06-27 | 다운그레이드 | Goldman | Neutral → Sell |
| 2018-12-07 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2018-12-07 | 재개 | Credit Suisse | Neutral |
| 2017-12-05 | 다운그레이드 | Northcoast | Buy → Neutral |
| 2017-11-08 | 개시 | Goldman | Neutral |
| 2017-09-21 | 업그레이드 | Northcoast | Neutral → Buy |
| 2017-01-10 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2016-09-27 | 다운그레이드 | Raymond James | Mkt Perform → Underperform |
| 2016-08-26 | 개시 | Macquarie | Neutral |
| 2016-07-12 | 개시 | Credit Suisse | Outperform |
| 2016-03-22 | 개시 | Sterne Agee CRT | Neutral |
| 2016-03-16 | 다운그레이드 | Stifel | Buy → Hold |
| 2016-03-10 | 다운그레이드 | UBS | Neutral → Sell |
| 2015-12-08 | 재확인 | Stifel | Buy |
| 2015-11-10 | 개시 | Cantor Fitzgerald | Hold |
모두보기
Factset Research Systems Inc 주식(FDS)의 최신 뉴스
ARQQ H1'26 Earnings: revenue estimate is 1.10M USD - TradingView
MANU Q3'26 Earnings: revenue estimate is 220.94M USD - TradingView
StubHub Holdings, Inc. Stock 12‑Month Price Target Raised to $12.85, Implies 71% Upside - TradingView
Dynatrace, Inc. Stock 12‑Month Price Target Cut to $44.45, Implies 28% Upside - TradingView
Doximity, Inc. Stock 12‑Month Price Target Cut to $31.11, Implies 33% Upside - TradingView
STAAR Surgical Company Stock 12‑Month Price Target Raised to $25, Implies 15% Downside - TradingView
Jack In The Box Inc. Stock 12‑Month Price Target Cut to $17.87, Implies 40% Upside - TradingView
Cisco Systems, Inc. Stock 12‑Month Price Target Raised to $109.44, Implies 7% Upside - TradingView
Tencent Holdings Ltd Stock 12‑Month Price Target Cut to HKD 724.18, Implies 57% Upside - TradingView
FactSet Research stock (US3030751057): Shares drop 6.5% amid partnership news - AD HOC NEWS
North American Construction Group Ltd. Stock 12‑Month Price Target Raised to $17.05, Implies 19% Upside - TradingView
Doximity, Inc. Stock 12‑Month Price Target Cut to $32.74, Implies 40% Upside - TradingView
CVS Health Corporation Stock 12‑Month Price Target Raised to $100.12, Implies 2% Upside - TradingView
Schrodinger, Inc. Stock 12‑Month Price Target Cut to $20.88, Implies 64% Upside - TradingView
Jack In The Box Inc. Stock 12‑Month Price Target Cut to $17.93, Implies 40% Upside - TradingView
IDEXX Laboratories, Inc. Stock 12‑Month Price Target Cut to $714.36, Implies 35% Upside - TradingView
Contineum Therapeutics, Inc. Stock 12‑Month Price Target Raised to $22.33, Implies 58% Upside - TradingView
Akamai Technologies, Inc. Stock 12‑Month Price Target Raised to $157.5, Implies 2% Downside - TradingView
Tencent Holdings Ltd Stock 12‑Month Price Target Cut to HKD 726.3, Implies 57% Upside - TradingView
SK hynix Inc. Stock 12‑Month Price Target Raised to KRW 1944897.86, Implies 2% Downside - TradingView
Korea Electric Power Corporation Stock 12‑Month Price Target Cut to $19.71, Implies 43% Upside - TradingView
A Look at FactSet Research Systems Inc (FDS) After 6.5% Decline -- GF Value $502.77 vs Price $201.87 - GuruFocus
Takeda Pharmaceutical Company Limited Stock 12‑Month Price Target Cut to $18.54, Implies 13% Upside - TradingView
Korea Electric Power Corporation Stock 12‑Month Price Target Cut to $20.58, Implies 47% Upside - TradingView
Dynatrace, Inc. Stock 12‑Month Price Target Cut to $46.14, Implies 18% Upside - TradingView
Zentalis Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $6.5, Implies 52% Upside - TradingView
Nexxen International Ltd. Stock 12‑Month Price Target Raised to $11.89, Implies 60% Upside - TradingView
Milestone Pharmaceuticals Inc. Stock 12‑Month Price Target Cut to $6.33, Implies 233% Upside - TradingView
Global-E Online Ltd. Stock 12‑Month Price Target Cut to $46.86, Implies 55% Upside - TradingView
National Vision Holdings, Inc. Stock 12‑Month Price Target Cut to $33.09, Implies 58% Upside - TradingView
CMPS Stock 12‑Month Price Target Raised to $21.37, Implies 128% Upside - TradingView
FactSet Research Systems Inc. stock underperforms Wednesday when compared to competitors - MSN
FactSet And Valutico Link Private Market Valuations To Support FDS Story - simplywall.st
Under Armour, Inc. Stock 12‑Month Price Target Cut to $6.1, Implies 21% Upside - TradingView
Takeda Pharmaceutical Company Limited Stock 12‑Month Price Target Cut to $18.55, Implies 13% Upside - TradingView
Ralliant Corporation Stock 12‑Month Price Target Raised to $58.64, Implies 1% Downside - TradingView
Karman Holdings Inc. Stock 12‑Month Price Target Cut to $111.44, Implies 78% Upside - TradingView
Korea Electric Power Corporation Stock 12‑Month Price Target Cut to $20.62, Implies 48% Upside - TradingView
Caterpillar, Inc. Stock 12‑Month Price Target Raised to $947.86, Implies 4% Upside - TradingView
Alto Neuroscience, Inc. Stock 12‑Month Price Target Raised to $35.52, Implies 44% Upside - TradingView
National Vision Holdings, Inc. Stock 12‑Month Price Target Cut to $34.36, Implies 64% Upside - TradingView
COMPASS PathwaysAmerican Depository Shares Stock 12‑Month Price Target Raised to $21.3, Implies 127% Upside - TradingView
Certara, Inc. Stock 12‑Month Price Target Cut to $7.62, Implies 50% Upside - TradingView
Ralliant Corporation Stock 12‑Month Price Target Raised to $57.27, Implies 3% Downside - TradingView
PagSeguro Digital Ltd. Stock 12‑Month Price Target Cut to $12.36, Implies 26% Upside - TradingView
DXC Technology Company Stock 12‑Month Price Target Cut to $11.67, Implies 31% Upside - TradingView
FactSet Research Systems (FDS) Drops 5.3% to $204.53 - AlphaStreet
TriSalus Life Sciences, Inc. Stock 12‑Month Price Target Cut to $8.8, Implies 93% Upside - TradingView
PepGen Inc. Stock 12‑Month Price Target Cut to $10, Implies 495% Upside - TradingView
Neurogene Inc. Stock 12‑Month Price Target Raised to $77.86, Implies 147% Upside - TradingView
Avalo Therapeutics, Inc. Stock 12‑Month Price Target Raised to $48.7, Implies 144% Upside - TradingView
Factset Research Systems Inc (FDS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.07%
0.55%
자본화:
|
볼륨(24시간):